Alzheimer’s disease, dementia, and stem cell therapy

Alzheimer’s disease (AD) represents arguably the most significant social, economic, and medical crisis of our time. Characterized by progressive neurodegenerative pathology, AD is first and foremost a condition of neuronal and synaptic loss. Repopulation and regeneration of depleted neuronal circuitry by exogenous stem cells is therefore a rational therapeutic strategy. This review will focus on recent advances in stem cell therapies utilizing animal models of AD, as well as detailing the human clinical trials of stem cell therapies for AD that are currently undergoing development.

[1]  F. LaFerla,et al.  Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss , 2015, Hippocampus.

[2]  P. Lee,et al.  Mesenchymal Stem Cells Increase Hippocampal Neurogenesis and Neuronal Differentiation by Enhancing the Wnt Signaling Pathway in an Alzheimer's Disease Model , 2015, Cell transplantation.

[3]  S. Kang,et al.  Human adipose tissue‐derived mesenchymal stem cells improve cognitive function and physical activity in ageing mice , 2013, Journal of neuroscience research.

[4]  James Adjaye,et al.  Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer’s disease donor as a model for investigating AD-associated gene regulatory networks , 2015, BMC Genomics.

[5]  M. Chopp,et al.  Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model , 2013, Neurobiology of Aging.

[6]  Qi Zhang,et al.  Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer's disease , 2016, Journal of neurochemistry.

[7]  P. Vallotton,et al.  Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease , 2016, Scientific Reports.

[8]  M. Shelanski,et al.  Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind). , 2007, Journal of Alzheimer's disease : JAD.

[9]  C. Cotman,et al.  Rescue of radiation-induced cognitive impairment through cranial transplantation of human embryonic stem cells , 2009, Proceedings of the National Academy of Sciences.

[10]  Y. Naaldijk,et al.  Effect of systemic transplantation of bone marrow‐derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice , 2017, Neuropathology and applied neurobiology.

[11]  J. Cummings,et al.  Alzheimer’s disease drug-development pipeline: few candidates, frequent failures , 2014, Alzheimer's Research & Therapy.

[12]  Sudharsana Rao Ande,et al.  O-GlcNAc modification: why so intimately associated with phosphorylation? , 2011, Cell Communication and Signaling.

[13]  Fang Li,et al.  Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells , 2011, Cell Research.

[14]  A. Salgado,et al.  Secretome of Mesenchymal Progenitors from the Umbilical Cord Acts as Modulator of Neural/Glial Proliferation and Differentiation , 2014, Stem Cell Reviews and Reports.

[15]  D. German,et al.  Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease , 2006, The Journal of comparative neurology.

[16]  F. Collette,et al.  Alzheimer' Disease as a Disconnection Syndrome? , 2003, Neuropsychology Review.

[17]  J. Suh,et al.  Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation , 2012, Neurobiology of Aging.

[18]  E. Mufson,et al.  The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Gideon Rechavi,et al.  Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient , 2009, PLoS medicine.

[20]  Il-Sun Kim,et al.  Human neural stem cells alleviate Alzheimer-like pathology in a mouse model , 2015, Molecular Neurodegeneration.

[21]  S. Lee,et al.  Improvement of cognitive function and physical activity of aging mice by human neural stem cells over-expressing choline acetyltransferase , 2013, Neurobiology of Aging.

[22]  C. Fong,et al.  Teratomas from pluripotent stem cells: A clinical hurdle , 2010, Journal of cellular biochemistry.

[23]  J. Kessler,et al.  The Controlled Generation of Functional Basal Forebrain Cholinergic Neurons from Human Embryonic Stem Cells , 2011, Stem cells.

[24]  Jong Min Lee,et al.  Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial , 2015, Alzheimer's & dementia.

[25]  H-M Chung,et al.  Placenta-derived mesenchymal stem cells improve memory dysfunction in an Aβ1–42-infused mouse model of Alzheimer's disease , 2013, Cell Death and Disease.

[26]  D. Selkoe,et al.  The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons. , 2014, Human molecular genetics.

[27]  H. Baharvand,et al.  Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats. , 2009, Differentiation; research in biological diversity.

[28]  Maria Sundberg,et al.  Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease. , 2015, Cell stem cell.

[29]  Yeisoo Yu,et al.  Uncovering the novel characteristics of Asian honey bee, Apis cerana, by whole genome sequencing , 2015, BMC Genomics.

[30]  S. Böhm,et al.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC , 2011, Cell Communication and Signaling.

[31]  P. Thorner,et al.  Angiomyeloproliferative lesions following autologous stem cell therapy. , 2010, Journal of the American Society of Nephrology : JASN.

[32]  S. Fazel,et al.  Mesenchymal stem cells engineered to overexpress stem cell factor improve cardiac function but have malignant potential. , 2008, Journal of Thoracic and Cardiovascular Surgery.

[33]  Thomas Vierbuchen,et al.  Induction of human neuronal cells by defined transcription factors , 2011, Nature.

[34]  I. Lombardo,et al.  The efficacy of RVT-101, a 5-ht6 receptor antagonist, as an adjunct to donepezil in adults with mild-to-moderate Alzheimer’s disease: Completer analysis of a phase 2b study , 2015, Alzheimer's & Dementia.

[35]  Nick C Fox,et al.  Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. , 2014, The New England journal of medicine.

[36]  M. Valenzuela,et al.  Modeling neurodegenerative disorders in adult somatic cells: A critical review , 2016, Frontiers in Biology.

[37]  K. Jin,et al.  Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Hamblin,et al.  Bystander Effect Fuels Human Induced Pluripotent Stem Cell‐Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke , 2015, Stem cells translational medicine.

[39]  L. Lue,et al.  Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases , 2005, Journal of neuroscience research.

[40]  E. Siemers,et al.  A phase 3 trial of semagacestat for treatment of Alzheimer's disease. , 2013, The New England journal of medicine.

[41]  A. Xuan,et al.  Effects of engrafted neural stem cells in Alzheimer's disease rats , 2009, Neuroscience Letters.

[42]  Shaonan Yang,et al.  Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model , 2013, Stem Cell Research & Therapy.

[43]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[44]  F. Müller,et al.  Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease , 2009, Proceedings of the National Academy of Sciences.

[45]  S. Kang,et al.  Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. , 2011, Stem cells and development.

[46]  R. Vassar,et al.  Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level , 2015, Molecular Neurodegeneration.

[47]  A. Verkhratsky,et al.  Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs , 2015, Neural plasticity.

[48]  G. Vertelov,et al.  High targeted migration of human mesenchymal stem cells grown in hypoxia is associated with enhanced activation of RhoA , 2013, Stem Cell Research & Therapy.

[49]  S. Kuroda,et al.  Migration and differentiation of nuclear fluorescence‐labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice , 2003, Neuropathology : official journal of the Japanese Society of Neuropathology.

[50]  Dmitry A Markov,et al.  Neurovascular unit on a chip: implications for translational applications , 2013, Stem Cell Research & Therapy.

[51]  Robert Krencik,et al.  Medial ganglionic eminence–like cells derived from human embryonic stem cells correct learning and memory deficits , 2013, Nature Biotechnology.

[52]  N. Zilka,et al.  Mesenchymal stem cells rescue the Alzheimer's disease cell model from cell death induced by misfolded truncated tau , 2011, Neuroscience.

[53]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[54]  R. Coimbra,et al.  Revisitingmolecular serotyping of Streptococcus pneumoniae , 2015, BMC Genomics.

[55]  J. Shimizu,et al.  Restoration of spatial memory dysfunction of human APP transgenic mice by transplantation of neuronal precursors derived from human iPS cells , 2013, Neuroscience Letters.